T G Brott

发表

Early stroke treatment associated with better outcome: the ninds rt-pa stroke study

J. Grotta, J. Marler, B. Tilley, 2000, Neurology.

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke

M Frankel, J. Broderick, J. Marler, 1998, Neurology.

Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage

J. Broderick, T. Brott, T. Tomsick, 1994, Stroke.

A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity

P D Lyden, J. Broderick, T. Brott, 2001, Stroke.

Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality

J. Broderick, T. Brott, T. Tomsick, 1993, Stroke.

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

P D Lyden, J. Grotta, W. Thies, 1996, Circulation.

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

P D Lyden, M Frankel, D. Tanné, 1999, Stroke.